PHARMA TECHNOLOGY A/S: Financial statements 2025
CVR: 20826746
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PHARMA TECHNOLOGY A/S (CVR 20826746) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 48,337,049 and a net result of DKK 12,305,927 compared with DKK 9,046,574 the year before. That is an increase of 39.1% compared with the year before. Equity in the 2025 report amounted to DKK 12,805,927. The solvency ratio was 37.6%.
- Gross Profit
- DKK 48,337,049
- Profit/Loss
- DKK 12,305,927
- Equity
- DKK 12,805,927
- Total Assets
- DKK 34,100,530
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 48.3 mio. | 12.3 mio. | 12.8 mio. | 0 |
| 2024 | - | 34.7 mio. | 9 mio. | 9.5 mio. | 24 |
| 2023 | - | 28.3 mio. | 10.1 mio. | 10.6 mio. | 15 |
| 2022 | - | 20.3 mio. | 7.1 mio. | 7.6 mio. | 11 |
| 2021 | - | 19.2 mio. | 7.6 mio. | 8.1 mio. | 11 |
Official annual report
How creditworthy is PHARMA TECHNOLOGY A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PHARMA TECHNOLOGY A/S has published its annual report for 2024. Gross profit came to DKK 34,739,215, and the net result was DKK 9,046,574.
About PHARMA TECHNOLOGY A/S
PHARMA TECHNOLOGY A/S is a Danish company of the type Aktieselskab based in Køge, founded in 1998. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Flemming Sten Pedersen. The board consists of Flemming Sten Pedersen, Inge Holsted Hansen and Svenn Ryberg Hansen. The company is owned by FPIH HOLDING ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 48,337,049 and a net result of DKK 12,305,927 compared with DKK 9,046,574 the year before. Equity in the 2025 report amounted to DKK 12,805,927.